Within 90 days after hospitalization, 2202 patients were prescribed a non-selective beta-blocker, of which carvedilol (53%) and sotalol (40%) were the most prevalent. Selective beta-blockers were ...

Cardioselective beta-blockers do not appear to increase the rate of exacerbations in patients with chronic obstructive pulmonary disease. Cardioselective beta-blockers do not appear to increase ...

Some beta blockers are selective and specifically target the beta 1 receptor. These are called cardioselective agents. Nonselective beta blockers are those that bind to both types of receptors.

Cardioselective beta-blockers act on beta-1 more than beta-2 and thus will not trigger or worsen asthma as much as non-cardioselective beta-blockers. Carvedilol and labetalol are non-selective ...

If you’ve been there, then you know that all these pesky physical symptoms only make you feel even more out of control. But ...

Some beta blockers are selective and block the beta 1 receptor more than the beta 2 receptor. These are called cardioselective agents. Nonselective beta blockers are those that bind to both types ...

Carvedilol is a non-selective beta-blocker that works ... Metoprolol is a cardioselective beta-blocker, which means it has more affinity to block beta-1 receptors primarily located in the heart ...

Of the 3,371 patients evaluated, 31 percent—more than 1000—received cardio-selective ... not on beta-blockers died. "What was observed in the population, beta blockers, especially ...

Our findings in a large, population-based registry of over 20 000 patients with a recent hospitalization for documented HF suggest that prescription of a non-selective beta-blocker is associated ...